Amid financial issues, Idorsia is hoping the resistant hypertension drug would b...
The country returns to the EU’s research programme after a Brexit-related absenc...
Patient information on the Janssen CarePath was accessed, but the true extent of...
Cidara will also receive $7m in milestone payments for the drug-Fc conjugate as ...
Veracyte has announced a partnership with Gustave Roussy to support biopharmaceu...
IMIDomics has entered an agreement to license TNAX Biopharma’s IMB1001 to treat ...
Novo Nordisk has entered a collaboration with The Broad Institute to detect drug...
Portfolio biopharmaceutical company Apollo Therapeutics has secured $226.5m in a...
Nimbus plans to use these funds to aid new drug discovery efforts and plans to c...
"We were bullied into unfair and undemocratic terms in contracts that were total...
A lot turns on what “bona fide competition” means.
“We could reduce right now cancer by 50% in the next 25 years by active navigati...
Republicans on three key House committees have reconciled differing legislative ...
More older adults have been hospitalized for Covid-19 over the past several week...
Astellas was so sure that one of its drugs was going to be selected as part of M...
Nimbus Therapeutics said Wednesday it has raised $210 million in venture capital...
